Both hsCRP and IL-6 are well-characterized inflammatory markers in type 2 diabetes [19–24], being independently related to insulin resistance [32] and to the progression of atherosclerosis [33]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.